2 unknown. 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Jordan Feld: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UHN Inpatient Hepatitis C & B Screening Quality Improvement - Hepatitis C, Hepatitis B | Phase 4 | Unknown | Jordan Feld | 2920 | 2024-02-01 | 2024-02-08 |
| Transplantation Using Hepatitis C Positive Donors, A Safety Trial Glecaprevir 300 MG / Pibrentasvir 120 MG Oral Tablet, Ezetimibe 10Mg Oral Tablet, Ex Vivo Lung Perfusion - Lung Transplant Infection, Heart Transplant Infection | Phase 3 | Unknown | Jordan Feld | 40 | 2018-08-06 | 2019-07-12 |
Hepatitis C (2) · Hepatitis B (1)
Ezetimibe (1) · Quality Improvement (1) · Tablets (1) · glecaprevir (1) · pibrentasvir (1)
Canada (2)